ArcticZymes Technologies Logo

ArcticZymes Technologies

Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.

AZT | BR

Overview

Corporate Details

ISIN(s):
NO0010014632
LEI:
5967007LIEEXZXGR7K47
Country:
Norway
Address:
FORSKNINGSPARKEN, 9019 TROMSØ
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ArcticZymes Technologies is a life sciences company specializing in the development, manufacturing, and sale of novel recombinant enzymes. With over 30 years of focused expertise, the company develops unique, high-performance enzymes, often derived from Arctic marine organisms, that are engineered to function in challenging conditions such as high-salt and low-temperature environments. Its products are critical components for customers in the molecular research, diagnostics (MDx), therapeutics, and biopharmaceutical manufacturing sectors, with key applications in gene therapy, vaccine production, and DNA purification. The company provides customized enzymatic solutions through close collaboration with its clients to advance molecular science.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 22:00
Director's Dealing
Long-Term Incentive Plan - grant of share options to primary insiders - Attachm…
English 1.5 MB
2025-11-10 22:00
Remuneration Information
Long-Term Incentive Plan - grant of share options to primary insiders
English 2.3 KB
2025-11-06 07:00
Earnings Release
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 272.3 KB
2025-11-06 07:00
Quarterly Report
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 1.7 MB
2025-11-06 07:00
Investor Presentation
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 2.9 MB
2025-11-06 07:00
Earnings Release
ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and…
English 6.5 KB
2025-10-30 13:46
Report Publication Announcement
ArcticZymes Technologies ASA: Invitation to presentation of Q3 and 9M 2025 resu…
English 1.1 KB
2025-10-29 08:00
Regulatory News Service
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess …
English 184.8 KB
2025-10-29 08:00
Regulatory News Service
ArcticZymes ASA Appoints New Exclusive European Distributor for its Bioprocess …
English 4.8 KB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 2.8 MB
2025-09-16 10:00
Investor Presentation
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Confere…
English 2.8 MB
2025-09-16 10:00
Report Publication Announcement
ArcticZymes Technologies to present at the Pareto Securities 16th Healthcare Co…
English 776 bytes
2025-09-16 10:00
Report Publication Announcement
ArcticZymes Technologies presenterer på Pareto Securities 16 Healthcare Confere…
Norwegian 693 bytes
2025-08-14 18:00
Director's Dealing
ArcticZymes Technologies ASA - Mandatory notification of trades by close associ…
English 205.9 KB
2025-08-14 18:00
Director's Dealing
ArcticZymes Technologies ASA - Mandatory notification of trades by close associ…
English 945 bytes

Automate Your Workflow. Get a real-time feed of all ArcticZymes Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ArcticZymes Technologies

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ArcticZymes Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Chemomab Therapeutics Ltd. Logo
Develops antibody drugs neutralizing CCL24 for severe fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and sells prescription, OTC, and nutritional products for human use.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, produces, and sells advanced Traditional Chinese Medicine (TCM) herbal products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Global manufacturer of OTC medicines and health supplements distributed through pharmacies.
South Korea
034940
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan
4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden
CINPHA
Cingulate Inc. Logo
Developing once-daily, precision timed-release drugs for ADHD and anxiety.
United States of America
CING
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway
CRNA
CITIUS ONCOLOGY, INC. Logo
Commercializing LYMPHIR™, an FDA-approved targeted therapy for cutaneous T-cell lymphoma.
United States of America
CTOR
Citius Pharmaceuticals, Inc. Logo
Late-stage biopharma developing critical care products for oncology, infections, and stem cells.
United States of America
CTXR

Talk to a Data Expert

Have a question? We'll get back to you promptly.